Reports for ABBVIE CORPORATION

Company Name

ABBVIE CORPORATION

Totals

Shortage reports

121

Actual shortage: 1 (1%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (4%)
Resolved: 115 (95%)

Discontinuation Reports

13

To be discontinued: 1 (8%)
Discontinued: 9 (69%)
Reversed: 3 (23%)

Late reports

6 (4%)

Overdue reports

2 (100%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ZYMAR 0.3% SOLUTION Resolved 2023-11-14 2023-12-07 210159

Showing 121 to 121 of 121

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACULAR LS 0.4% SOLUTION To be discontinued 2025-01-23 2025-01-23 248365
ALPHAGAN 0.2% LIQUID Reversed 2021-12-09 2023-12-14 150885
HOLKIRA PAK 50MG 12.5MG 250MG 75MG KIT TABLET Discontinued 2017-11-30 2018-08-30 31302
HUMIRA 40MG SOLUTION Discontinued 2020-06-29 2020-11-19 119141
LUPRON 5MG SOLUTION Discontinued 2022-01-31 2022-08-17 153896
MODERIBA 600MG TABLET Discontinued 2017-11-20 2018-05-07 29835
MODERIBA 200MG TABLET Discontinued 2017-11-21 2018-08-30 29907
MODERIBA 400MG TABLET Discontinued 2017-11-30 2018-08-30 31316
NORVIR 80MG SOLUTION Discontinued 2019-02-20 2019-04-01 76354
SKYRIZI 75MG SOLUTION Discontinued 2025-01-27 2025-02-06 248607
TECHNIVIE 12.5MG 75MG 50MG TABLET Discontinued 2017-11-20 2018-05-07 29839
VIBERZI 75MG TABLET Reversed 2022-03-23 2022-06-29 157156
VIBERZI 100MG TABLET Reversed 2022-03-23 2022-06-22 157159

Showing 1 to 13 of 13